GLPwatch
Trials (2081)
Page 15 of 35.
- A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
- Effects of GLP-1 Analogue Combined With Metformin and Metformin on Gonadal and Metabolic Profiles in Chinese Overweight/Obese PCOS Patients With Hyperandrogenemia.
- Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
- Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function
- The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes
- Investigation of Efficacy and Safety of Three Dose Levels of Subcutaneous Semaglutide Once Daily Versus Placebo in Subjects With Non-alcoholic Steatohepatitis.
- A Trial Comparing Insulin Degludec/Liraglutide and Insulin Degludec in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Therapy and Metformin With or Without One Other Oral Antidiabetic Drug (OAD)
- Safety and Efficacy of Exenatide Once Weekly Versus Liraglutide in Subjects With Type 2 Diabetes
- A Study of LY3305677 in Participants With Type 2 Diabetes
- Semaglutide in Patients Undergoing Transcatether Aortic Valve Replacement
- Umbilical Cord Mesenchymal Stem Cells and Liraglutide in Diabetes Mellitus
- Semaglutide Treatment, Appetite, and Eating Behavior: Long-term Effects
- Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
- Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder
- Effect of Semaglutide on Cannabis Use in Adults With Cannabis Use Disorder
- A Study to Evaluate ITCA 650 Compared to Glimepiride for the Treatment of Type 2 Diabetes
- A Multiple Dose Study of LY3502970 in Healthy Participants
- A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.
- A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients
- Separate and Combined Extrapancreatic Effects of the Incretin Hormones
- Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
- Semaglutide GLP1 Agonists With Degludec Basal-bolus Insulin in Early Type 1 Diabetes to Basal-bolus
- A Research Study to See How Well CagriSema Compared to Tirzepatide Helps People With Obesity Lose Weight
- Optimization of Obesity for Total Knee Replacement With Glucagon-like Peptide-1 Receptor Agonist
- Exendin PET/CT for Imaging of Paragangliomas
- A Study of the Effect of (S)-Pindolol Benzoate (ACM-001.1) on Lean Body Mass (LBM) in Obese Patents During (PROACT 1), and Post-semaglutide Therapy (PROACT 2)
- A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
- Efficacy and Safety of Insulin Glargine/Lixisenatide Fixed Combination Versus Insulin Glargine Alone on Top of Metformin in Type 2 Diabetic Patients
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus
- TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
- A Study Comparing the Effects and Safety of Dulaglutide With Glimepiride in Type 2 Diabetes Mellitus
- The Cardiovascular Effect of GLP-1 Agonist, SGLT2 Inhibitor and Their Combination
- A Study of LY3502970 in Participants With Impaired and Normal Liver Function
- Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis
- GLP-1 Receptor Agonists and Alzheimer's Disease: A Multi-National Target Trial Emulation
- A Research Study Investigating Semaglutide in People With Early Alzheimer's Disease (EVOKE Plus)
- A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation
- Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
- A Study to Test How BI 456906 is Taken up in the Blood of People With and Without Kidney Problems
- Phase 2 Study of HEC88473 Injection in Subjects With Type 2 Diabetes Mellitus
- A Research Study of NNC0165-1562 and Semaglutide in People Who Are Overweight or Obese
- SELECT-LIFE: A Research Study Looking at Long-term Effects of Semaglutide in People Who Took Part in the SELECT Cardiovascular Outcomes Trial
- A Study of Dulaglutide in Chinese Participants
- Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With Ozempic®
- Effects of Exenatide Long-Acting Release on Glucose Control and Safety in Subjects With Type 2 Diabetes Mellitus(DURATION - 1)
- Relationship Between Improvement in Insulin Secretion and Decrease in HbA1c in GLP-1 RA Therapy in T2DM Patients
- Comparison of Three Liraglutide Formulations in Healthy Volunteers
- Effects of Exenatide on Motor Function and the Brain
- Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.
- MODERN-Dental: Pediatric Obesity, Cardiometabolic Risks, And Periodontal Disease
- GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin
- Liraglutide in the Treatment of Type 1 Diabetes Mellitus
- Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes
- A Study to Evaluate ALN-2232 in Participants With Obesity
- A Study of Retatrutide (LY3437943) in Participants With Obesity and Cardiovascular Disease
- DOORS: A Research Study to Understand How Oral Semaglutide Works in People With Type 2 Diabetes Who Change From Dipeptidyl Peptidase-4 Inhibitor (DPP4i) Treatment to Oral Semaglutide in Italy
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)
- Metabolic Interventions (Time-Restricted Eating, GLP1 Receptor Agonist, and Heart Healthy Diet) to Improve Cardiometabolic Health in Prostate Cancer Patients During Androgen Deprivation Therapy, IMPACT-ADT Trial
- The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
- The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects